GlassScriptPhysician profile
Lorry Aitkens
NPI 1457040768
$2,653.13
in general payments reported to CMS, 2019-2025
16 companies · $2,133 in 2025
The $2,133 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $520 · 2025: $2,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,486 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,486.15 |
| Education | $166.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $601.15 | 2024-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $447.30 | 2024-2025 | Nemluvio |
| Genzyme Corporation | $416.52 | 2024-2025 | |
| Janssen Biotech, INC. | $244.77 | 2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $232.23 | 2025 | Dupixent |
| Abbvie INC. | $160.45 | 2025 | |
| Janssen Scientific Affairs, LLC | $101.98 | 2025 | Tremfya |
| Krystal Biotech INC | $100.14 | 2025 | Vyjuvek |
| Novartis Pharmaceuticals Corporation | $68.12 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.34 | 2024-2025 | Spevigo |
| Lilly USA, LLC | $56.81 | 2024-2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $53.42 | 2025 | |
| Mallinckrodt Hospital Products INC. | $36.96 | 2024 | Acthar |
| Organon LLC | $27.89 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $23.55 | 2025 | Sotyktu |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.50 | 2025 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorry Aitkens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.